-
cell-based disease modelling, neuroscience and translational research. Through planned secondments, you will also gain experience with MLC animal models and computational chemistry approaches
-
at the MITH research group, with the anticipated PhD defence at the Faculty of Medicine, Vrije Universiteit Brussel. You will contribute to the development of GPRC5B-targeting nanobodies from initial discovery
-
. Throughout the PhD project, you will have opportunities to further develop your scientific and transferable skills through the POLARIS doctoral training programme.
-
, computational biology and clinical neurology and collaborate with POLARIS partners across Europe. Through planned secondments, you will gain experience in omics research, biomarker development and patient
-
, disease monitoring and treatment evaluation. You will work closely with researchers in human genetics, computational biology and clinical neurology and collaborate with POLARIS partners across Europe
-
patient-informed treatment priorities. To achieve this, POLARIS brings together expertise in leukodystrophy biology, advanced disease models, therapeutic innovation, biomarker development, clinical
-
patient-informed treatment priorities. To achieve this, POLARIS brings together expertise in leukodystrophy biology, advanced disease models, therapeutic innovation, biomarker development, clinical
-
4 Sep 2026 Job Information Organisation/Company Amsterdam UMC Research Field Medical sciences » Medicine Psychological sciences » Psychology Researcher Profile First Stage Researcher (R1
-
https://www.academictransfer.com/en/jobs/363696/msca-dn-phd-in-oligodendrocyte-… Requirements Specific Requirements We are looking for a candidate with a Master's degree in Life Sciences, preferably in
-
institutions and several industrial partners with extensive expertise in quantitative imaging, image analysis and imaging technology. By conducting research in both academic and industrial settings, PhD